PDEX Stock Risk & Deep Value Analysis

Pro-Dex Inc

Healthcare โ€ข Medical Instruments & Supplies

DVR Score

1.4

out of 10

Distressed

The Bottom Line on PDEX

We analyzed Pro-Dex Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran PDEX through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Apr 20, 2026โ€ขRun Fresh Analysis โ†’โ€ข

Get notified when PDEX moves

Same alert types as Telegram โ€” presets or custom thresholds in your ๐Ÿ”” feed.

๐Ÿ“ˆPDEX Performance Overview3yr weekly

๐Ÿ“Š

Unlock PDEX Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

PDEX Quality Rating

1.4
1.0
Growth
2.0
Profitability
6.0
Health
2.0
Capital allocation
1.0
Momentum

PDEX Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Low

Market Risk

Medium

About Pro-Dex Inc (PDEX)

Sector

Healthcare

Industry

Medical Instruments & Supplies

Market Cap Category

small

Market Cap

$171.20M

PDEX Deep Value Analysis

Pro-Dex Inc. remains a financially robust and profitable specialized contract manufacturer, characterized by a strong balance sheet and stable profitability (TTM revenue $66.59M, net income $8.98M, TTM P/E ~20.16 based on current price and EPS). Fiscal 2025 revenue grew 23.68% YoY. However, its fundamental business model, while essential and reliable, does not exhibit the disruptive innovation, exponential scalability, or market-transforming catalysts essential for 10x growth within 3-5 years. Growth is primarily incremental, driven by existing client relationships and operational efficiencies in a niche market, rather than market disruption. There have been no material changes since the last analysis that would alter its long-term trajectory towards hyper-growth. While stable and operationally sound, its profile does not align with high-risk, high-reward, 10x potential.

PDEX Research Sources

Research sources

No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.

For educational context only. Not financial advice.

PDEX Red Flags & Warning Signs

  • โš 

    Failure to meet modest earnings expectations for Q3/Q4 2026

  • โš 

    Slowdown in capital expenditures or innovation within the medical/dental device sector

  • โš 

    Loss of a significant contract manufacturing client

Unlock PDEX Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

PDEX Financial Health Metrics

Market Cap

$171.20M

P/E Ratio

15.10

Profit Margin

15.73%

Debt-to-Equity

0.42

Beta (Volatility)

-0.05

Earnings Per Share

$3.40

PDEX Competitive Moat Analysis

Moat Rating

Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Switching CostsIntangible Assets/IPCost Advantages (from operational efficiency in niche)

Pro-Dex's moat is durable due to the specialized nature of its products, the high R&D and regulatory hurdles involved, and the deep integration with client product development, making it costly and risky for clients to switch suppliers. Its specific expertise is not easily replicated.

PDEX Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

PDEX Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขQ3 2026 Earnings (announced April 29, 2026)
  • โ€ขQ4 2026 Fiscal Year Earnings (expected May 7, 2026)

Medium-Term (6-18 months)

  • โ€ขPotential new specialized contract wins or expanded relationships with existing clients
  • โ€ขSustained demand in the dental and medical device markets

Long-Term (18+ months)

  • โ€ขContinued reliance of larger medical device companies on specialized contract manufacturers
  • โ€ขIntroduction of next-generation surgical/dental instruments

Catalysts & Growth Drivers

Sign up free to see growth catalysts

PDEX Bull Case: What Could Go Right

  • โœ“

    Sustained organic revenue growth acceleration (e.g., above 20% YoY for several quarters).

  • โœ“

    Announcement of a significant new partnership or a major expansion into a new, high-growth medical sub-segment.

  • โœ“

    Evidence of margin expansion driven by new, higher-value product lines.

Bull Case Analysis

Sign up free to see the bull case

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Pro-Dex Inc (PDEX)?

As of April 20, 2026, Pro-Dex Inc has a DVR Score of 1.4 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Pro-Dex Inc?

Pro-Dex Inc's market capitalization is approximately $171.2M. The company operates in the Healthcare sector within the Medical Instruments & Supplies industry.

What ticker symbol does Pro-Dex Inc use?

PDEX is the ticker symbol for Pro-Dex Inc. The company trades on the NCM.

What is the risk level for PDEX stock?

Our analysis rates Pro-Dex Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of PDEX?

Pro-Dex Inc currently has a price-to-earnings (P/E) ratio of 15.1. This is in line with broader market averages.

Is Pro-Dex Inc's revenue growing?

Pro-Dex Inc has reported revenue growth of 18.2%. The company is showing strong top-line momentum.

Is PDEX stock profitable?

Pro-Dex Inc has a profit margin of 15.7%. The company is profitable but margins are modest.

How often is the PDEX DVR analysis updated?

Our AI-powered analysis of Pro-Dex Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 20, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.